A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

被引：0
作者：
Steven J. Cohen
Mark M. Zalupski
Manuel R. Modiano
Paul Conkling
Yehuda Z. Patt
Peg Davis
Robert T. Dorr
Michelle L. Boytim
Evan M. Hersh
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] University of Michigan,undefined
[3] Arizona Clinical Research Center,undefined
[4] Virginia Oncology Associates,undefined
[5] US Oncology Phase I Group,undefined
[6] University of New Mexico,undefined
[7] University of Arizona,undefined
[8] AmpliMed Corporation,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Gemcitabine; Imexon; Pancreatic cancer; Phase I clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：287 / 294
页数：7
相关论文
共 124 条
[31]  
Wolff RA(undefined)undefined undefined undefined undefined-undefined
[32]  
Campos D(undefined)undefined undefined undefined undefined-undefined
[33]  
Lim R(undefined)undefined undefined undefined undefined-undefined
[34]  
Ding K(undefined)undefined undefined undefined undefined-undefined
[35]  
Clark G(undefined)undefined undefined undefined undefined-undefined
[36]  
Voskoglou-Nomikos T(undefined)undefined undefined undefined undefined-undefined
[37]  
Ptasynski M(undefined)undefined undefined undefined undefined-undefined
[38]  
Parulekar W(undefined)undefined undefined undefined undefined-undefined
[39]  
Hersh EM(undefined)undefined undefined undefined undefined-undefined
[40]  
Gschwind CR(undefined)undefined undefined undefined undefined-undefined
12345678910